Vitality Biopharma Inc (VBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VBIO | AMGN | GILD | CELG | VRTX |
| Company | Vitality Biopharma Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4195 | 274.18 | 65.32 | 108.01 | 392.81 |
| High | 0.4195 | 279.84 | 65.89 | 108.59 | 406.95 |
| Low | 0.3602 | 273.38 | 64.97 | 107.27 | 392.47 |
| Last | 0.3900 | 277.37 | 65.51 | 108.24 | 402.14 |
| Change | +0.0400 | +3.43 | +0.31 | +0.11 | +9.33 |
| % Change | +11.43% | +1.25% | +0.48% | +0.10% | +2.38% |
| Volume | 64,200 | 2,322,902 | 7,228,683 | 191,230,496 | 1,256,221 |
| 20-Day Average Volume | 94,425 | 2,242,985 | 7,433,584 | 16,188,930 | 999,486 |
| Previous Close | 0.3500 | 273.94 | 65.20 | 108.13 | 392.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.3413 | 269.69 | 67.33 | 108.17 | 398.90 |
| 20-Day Raw Stochastic | 57.88% | 87.11% | 13.02% | 63.25% | 51.46% |
| 20-Day Relative Strength | 52.80% | 52.79% | 32.15% | 64.69% | 47.81% |
| Weighted Alpha | -24.99 | +14.56 | -21.43 | +46.30 | +14.78 |
| Today's Opinion | 72% Buy | 24% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 56% Buy | 40% Sell | 100% Sell | 100% Buy | 24% Sell |
| Last Month's Opinion | 100% Buy | 8% Sell | 88% Sell | 100% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +29.44% since 10/04/21 | +1.60% since 04/24/24 | -2.34% since 04/24/24 | -1.97% since 11/13/19 | +0.34% since 04/24/24 |
| Low | 0.2502 on 10/06/21 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 391.70 on 04/30/24 |
| High | 0.5000 on 10/05/21 | 279.84 on 05/01/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 406.95 on 05/01/24 |
| 1-Month | |||||
| %Chg | -25.32% since 09/10/21 | -2.00% since 04/01/24 | -10.11% since 04/01/24 | +5.14% since 10/18/19 | -4.36% since 04/01/24 |
| Low | 0.2251 on 09/28/21 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 0.5413 on 09/13/21 | 283.91 on 04/02/24 | 72.85 on 04/02/24 | 110.70 on 11/13/19 | 420.87 on 04/02/24 |
| 3-Month | |||||
| %Chg | +100.00% since 07/09/21 | -14.54% since 02/01/24 | -16.18% since 02/01/24 | +13.63% since 08/20/19 | -7.31% since 02/01/24 |
| Low | 0.1400 on 07/15/21 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 0.8500 on 09/03/21 | 329.72 on 02/05/24 | 77.99 on 02/02/24 | 110.70 on 11/13/19 | 437.00 on 02/27/24 |
| 6-Month | |||||
| %Chg | +125.96% since 04/09/21 | +6.34% since 11/01/23 | -18.31% since 11/01/23 | +14.14% since 05/20/19 | +8.88% since 11/01/23 |
| Low | 0.1300 on 06/04/21 | 260.52 on 11/21/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 0.8500 on 09/03/21 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 19,968 | 146,934,848 | 81,179,024 | 77,035,920 | 101,525,288 |
| Shares Outstanding, K | 51,200 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -880,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 6,686,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | N/A | 767,000,000 | -4,170,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 4.09 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 11/12/21 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 16.36 | 10.99 | 29.48 |